Jun 14, 2019
World Cancer Immunotherapy Market Report 2019 - Outcome Potential / Fast Tracking / Funding / Technology Environment / Target Solutions
Feb 22, 2019
Global CAR T Cell Therapy Market 2017-2028: Market is Expected to Grow with a CAGR of Over 46%
Jan 17, 2019
Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Journey From Target to T Cell Product: A Platform to Identify Opportunities and Overcome Challenges, 2018 by DelveInsight
Sep 17, 2018
Inspyr to License Oncology Related Compounds to Ridgeway Therapeutics Inc.
Aug 30, 2018
CAR-T Therapies Market, 2030 - Over 350 Product Candidates Being Developed for Various Oncological Indications
Aug 17, 2018
Global $100+ Billion Cancer Immunotherapies Market to 2024 - 3,863 Cancer Immunotherapy Products in the Pipeline
Aug 03, 2018
CAR T Cell Therapy Market Global Trends, Growth Drivers, Targeted Antigens Opportunities and Forecast to 2028
Jun 14, 2018
Global CAR T Cell Therapy Market 2016-2026: The Most Hot Topic Discussed Among Oncologists Throughout the Globe
Jun 11, 2018
Replimune Appoints Dr. Hyam I. Levitsky to Board of Directors
May 31, 2018
Lymphocytic Leukemia Pipeline Market (ALL) 2018 Analysis, Therapeutics and Drug Research Report
May 16, 2018
FogPharma Secures $66 Million Series B Financing
Mar 07, 2018
Global and USA Cancer Immunotherapy Market 2017-2022: This Space will be a Significant Revenue Generator (Excess of $80 Billion) for the Biopharmaceutical Industry by 2020
Mar 01, 2018
Lower Female Reproductive System Cancers Drug Development Pipeline Review, 2017
Jan 31, 2018
Global Engineered T-Cells Market Expected to Reach $2,124 Million, by 2023 - Allied Market Research
Jan 12, 2018
JUNO THERAPEUTICS INVESTIGATION BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Juno Therapeutics, Inc. - JUNO
Dec 20, 2017
Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership
Nov 27, 2017
Juno Therapeutics Appoints Ann L. Lee as Executive Vice President of Technical Operations and Patrick Y. Yang as Executive Vice President, Senior Advisor to the CEO
Oct 18, 2017
Breakfast Technical Briefing on Biotech Stocks -- BioCryst Pharma, Celgene, Juno Therapeutics, and Lexicon Pharma
Oct 18, 2017
Trianni and Juno Therapeutics Sign Licensing Agreement for Use of Trianni Transgenic Mouse Platform
Sep 18, 2017
LifeMine Therapeutics Launches with $55 Million Series A Financing